A team of industry experts awarded Nemera’s electronic add-on for ophthalmic droppers with a prestigious CPhI Award for Best Drug Delivery Device in its category
On 9 October, during the CPhI Pharma Awards Gala, e-Novelia, Nemera’s electronic add-on for ophthalmic droppers, was celebrated as the best-in-class innovation displayed at the show for “Excellence in Pharma: Drug Delivery Devices”.
e-Novelia, Nemera’s smart ophthalmic add-on, has been designed to make patients’ life easier, by offering increased comfort and optimised adherence to their treatments. It works in combination with Nemera’s preservative-free multidose eye dropper Novelia.
“There is no limit to Nemera’s ambition to serve patients. We already market devices in over 40 countries for millions of users. We’ll keep investing in new products and in state-of-the-art manufacturing equipment, to help even more patients with high quality drug delivery devices all over the world,” said Marc Haemel, CEO.
The ophthalmic add-on incorporates cutting-edge technology and unique features; Nemera have designed and developed the device to add new functions which couldn’t be provided by standard mechanical devices. Patients will benefit from enhanced instructions for use, immediate usage feedback and compliance information.
Patients will benefit from enhanced instructions for use,
immediate usage feedback and compliance information
e-Novelia combines these electronic benefits with improved ergonomics using mechanical features to make the device easier to activate and electronic functions to assist the patient in delivering drops accurately to the eyes.
This new technology will also be useful for healthcare professionals to tailor treatments and for researchers to perform more efficient clinical studies, for example.
e-Novelia has been designed to improve patients’ interaction with their drug by assisting them with:
Nemera’s smart eyedropper showcases several electronic features, which could be transferred across multiple device platforms:
“We are absolutely thrilled to receive this prestigious award,” said Denise Johnston, VP Global Sales. “The Novelia PFMD platform is already a huge success in the market, improving patients' daily lives by giving them an option on preservative-free formulations in a multi-dose eye dropper bottle, reducing allergic reactions and itchiness due to preservatives. Our innovation teams are blazing a trail on developing electronic devices to further enhance the patient experience with Novelia and these features can even be used universally for many of our other devices. It is wonderful to see this work recognised as being cutting edge and hugely motivating for our teams. Like our motto says ‘We put patients first'," added Johnston.
You can learn more about e-Novelia at www.nemera.net/smart-ophthalmic-add-on-e-novelia/